Amubarvimab/Romlusevimab: First Approval
Sheridan M. Hoy
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)AuthorizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDrug approvalPharmacotherapyIntensive care medicineCoronavirusDiseaseEmergency medicineInternal medicineVirologyInfectious disease (medical specialty)OutbreakDrugPharmacologyComputer securityComputer scienceSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCancer Immunotherapy and Biomarkers